NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$15.20
-6.81% today
Updated 2026-07-29
Market cap
$1.84B
P/E ratio
—
P/S ratio
2.73x
EPS (TTM)
$-1.53
Dividend yield
—
52W range
$10 – $19
Volume
1.8M
Novocure Ltd (NVCR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.20
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$55.73
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.5B | $0.6B | $0.7B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -25.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.